Most people notice this when air pressure changes rapidly, such as when a plane ascends or descends. This happens because the ...
Respiratory Syncytial Virus RSV is a common respiratory virus primarily affecting young children Here are some remedies to ...
Older people should take a new vaccine to protect them against Respiratory Syncytial Virus (RSV), according to new research ...
Leaders from the Pennsylvania Departments of Health and Insurance this week encouraged all Pennsylvanians to stay up to date on their annual vaccinations to protect against flu, COVID-19, and ...
GSK plc (NYSE:GSK) released topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, ...
Respiratory syncytial virus (RSV) is a leading cause of severe illness in infants, with no effective treatment. Results of a phase 2 trial suggested that ziresovir may have efficacy in the ...
Enanta Pharmaceuticals' EDP-323 shows promising Phase 2a trial results, significantly reducing RSV viral load and symptoms ...
Fall brings cooler days and more time indoors. This makes it easier for viruses like influenza, COVID-19 and respiratory ...
Figures show flu killed almost as many people as Covid over the past two winters as people are urged to get protected against ...
GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that Arexvy (MAL24086007ARZ) has been approved in Malaysia for ...
Forecasts suggest respiratory infections will be similar to last year's season. Vaccination rates will be a factor in the ...
GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that the Arexvy vaccine (MAL24086007ARZ) has been approved in Malaysia for respiratory syncytial virus (RSV). RSV is a common respiratory ...